Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The strong association of the HLA-B27 with AS was first discovered independently by groups in London and California in 1972 and has recently been confirmed beyond reasonable doubt by fine mapping in the latest and most sophisticated genome-wide association study (GWAS) published this July. Yet, despite nearly four decades of extensive research, the exact role that HLA-B27 plays in pathogenesis remains unknown. However, we believe that recent developments in three fields have allowed us to view this conundrum in a new light and to propose coherent theories of disease pathogenesis. These areas are as follows: (i) GWASs, (ii) studies of B27 biology and (iii) lessons from biologic therapies. In this review we will discuss these recent advances before discussing the current models of AS pathogenesis under investigation.

Original publication

DOI

10.1093/rheumatology/kes061

Type

Journal article

Journal

Rheumatology (Oxford)

Publication Date

09/2012

Volume

51

Pages

1529 - 1539

Keywords

Biological Products, Genetic Predisposition to Disease, Genome-Wide Association Study, HLA-B27 Antigen, Humans, Spondylitis, Ankylosing, Th17 Cells, Tumor Necrosis Factor-alpha